This is a prospective study to evaluate the sensitivity and specificity of Cu-64 DOTA-ECL1i PET/CT imaging to serve as a novel precision imaging tool for patie…

Head and Neck Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Head and Neck Squamous Cell Carcinoma HNSCC

~Estimated

~$10 – $6,250

Washington University School of MedicineNCT07659678

Phase 2

A Phase II Window of Opportunity in Preserving Laryngeal Function (WOLF) Trial

This trial will study the safety and tolerability and disease survival rates in adult patients with recurrent/metastatic (R/M) HNSCC when treated with carbopla…

Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Locally Advanced Laryngeal Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma

~Estimated

~$10 – $7,500

Matthew SpectorNCT07423078